SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-344303
Filing Date
2015-10-15
Accepted
2015-10-15 09:16:39
Documents
9
Period of Report
2015-12-03
Effectiveness Date
2015-10-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d24156ddef14a.htm DEF 14A 880106
2 GRAPHIC g24156g03d64.jpg GRAPHIC 58972
3 GRAPHIC g24156g03j06.jpg GRAPHIC 77963
4 GRAPHIC g24156g09i36.jpg GRAPHIC 23102
5 GRAPHIC g24156g16d40.jpg GRAPHIC 66076
6 GRAPHIC g24156g29m27.jpg GRAPHIC 65879
7 GRAPHIC g24156g42x55.jpg GRAPHIC 27891
8 GRAPHIC g24156g45d93.jpg GRAPHIC 55849
9 GRAPHIC g24156g48q41.jpg GRAPHIC 70768
  Complete submission text file 0001193125-15-344303.txt   1496755
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26642 | Film No.: 151159306
SIC: 2835 In Vitro & In Vivo Diagnostic Substances